Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Mary Kate Malecek, Mark Fiala, Mark Schroeder, James Dukeman, Armin Ghobadi, Keith Stockerl-Goldstein, Tanya Wildes, Ravi Vij

Research output: Contribution to journalLetterpeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment'. Together they form a unique fingerprint.